{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:19:36Z","timestamp":1787019576683,"version":"build-2736575974"},"reference-count":33,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,23]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Acute kidney injury (AKI) frequently follows hematopoietic cell transplantation (HCT). Soluble urokinase-type plasminogen activator receptor (suPAR) is a biomarker of AKI in the general population. We evaluated suPAR and its association with AKI requiring dialysis (AKI-D) in patients undergoing allogeneic HCT (alloHCT). Performance of suPAR was compared with serum creatinine (sCr) and neutrophil gelatinase-associated lipocalin (NGAL). Data were obtained from the Blood and Marrow Transplant Clinical Trials Network 1202 cohort, an observational study of 1709 alloHCT recipients. Adults aged \u226518 years with AKI-D after HCT were included. Adults who did not develop AKI were included as controls and matched 1:1. Periodic serum samples (7-90 days) were analyzed for NGAL, suPAR, and sCr. The 1:1 matched case-control groups (n = 62 each) were balanced in demographic variables, except for graft-versus-host disease prophylaxis. The median time from transplant to AKI-D was 2.6 months (range, 0.03-20.39). The day +7 suPAR level after HCT was higher in patients with AKI (median, 2.7 ng\/mL) than in controls (2.1 ng\/mL; P = .002). In the multivariate analysis, the day +7 suPAR level was associated with the development of AKI-D (P = .009). The area under the curve for the receiver operating characteristic curve for day +7 suPAR levels was 0.75. Neither NGAL nor sCr were associated with AKI-D. Elevated day +7 suPAR levels predicted AKI and lower overall survival (OS). The suPAR level at day +7 after HCT may be an early prognostic factor for the development of AKI-D and OS. Future prospective studies could evaluate this at different stages of AKI. This trial was registered at www.ClinicalTrial.gov as #NCT01879072.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016655","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T16:12:15Z","timestamp":1758730335000},"page":"6394-6401","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["Soluble urokinase plasminogen activator receptor and acute kidney injury in hematopoietic cell transplantation"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1199-7822","authenticated-orcid":false,"given":"Bhavna","family":"Bhasin-Chhabra","sequence":"first","affiliation":[{"name":"1Division of Nephrology and Hypertension, Mayo Clinic Arizona, Scottsdale, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-6843","authenticated-orcid":false,"given":"Tao","family":"Wang","sequence":"additional","affiliation":[{"name":"2Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, WI"},{"name":"3Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5611-7828","authenticated-orcid":false,"given":"John E.","family":"Levine","sequence":"additional","affiliation":[{"name":"4Division of Hematology\/Medical Oncology, Tisch Cancer Center Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Shenoy","sequence":"additional","affiliation":[{"name":"5Department of Pediatrics, Washington University in St. Louis, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5910-4571","authenticated-orcid":false,"given":"Miguel-Angel","family":"Perales","sequence":"additional","affiliation":[{"name":"6Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"7Department of Medicine, Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asad","family":"Bashey","sequence":"additional","affiliation":[{"name":"8Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hershel","family":"Raff","sequence":"additional","affiliation":[{"name":"9Department of Medicine, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Saber","sequence":"additional","affiliation":[{"name":"3Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"issue":"1","key":"2025122309411098000_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.ackd.2013.08.007","article-title":"The kidney effects of hematopoietic stem cell transplantation","volume":"21","author":"Sawinski","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"2025122309411098000_bib2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/ndt\/gfp485","article-title":"Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors","volume":"25","author":"Ando","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2025122309411098000_bib3","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/bmt.2015.357","article-title":"Acute kidney injury in HCT: an update","volume":"51","author":"Lopes","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"2025122309411098000_bib4","doi-asserted-by":"crossref","first-page":"5163789","DOI":"10.1155\/2016\/5163789","article-title":"Acute kidney injury in hematopoietic stem cell transplantation: a review","volume":"2016","author":"Krishnappa","year":"2016","journal-title":"Int J Nephrol"},{"issue":"2","key":"2025122309411098000_bib5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1046\/j.1523-1755.2002.00455.x","article-title":"Renal dysfunction in allogeneic hematopoietic cell transplantation","volume":"62","author":"Parikh","year":"2002","journal-title":"Kidney Int"},{"issue":"2","key":"2025122309411098000_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/nep.14132","article-title":"Definitions, phenotypes, and subphenotypes in acute kidney injury-moving towards precision medicine","volume":"28","author":"Rodrigues","year":"2023","journal-title":"Nephrology (Carlton)"},{"issue":"1","key":"2025122309411098000_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nm.4242","article-title":"Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease","volume":"23","author":"Hahm","year":"2017","journal-title":"Nat Med"},{"issue":"20","key":"2025122309411098000_bib8","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa1506362","article-title":"Soluble urokinase receptor and chronic kidney disease","volume":"373","author":"Hayek","year":"2015","journal-title":"N Engl J Med"},{"issue":"7-8","key":"2025122309411098000_bib9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00424-017-2026-7","article-title":"suPAR and chronic kidney disease-a podocyte story","volume":"469","author":"Zeier","year":"2017","journal-title":"Pflugers Arch"},{"issue":"4","key":"2025122309411098000_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-3083.2011.02511.x","article-title":"Soluble urokinase plasminogen activator receptor during allogeneic stem cell transplantation","volume":"73","author":"Haastrup","year":"2011","journal-title":"Scand J Immunol"},{"issue":"8","key":"2025122309411098000_bib11","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3390\/ijms18081662","article-title":"Elevated soluble urokinase plasminogen activator receptor and proenkephalin serum levels predict the development of acute kidney injury after cardiac surgery","volume":"18","author":"Mossanen","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2025122309411098000_bib12","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1911481","article-title":"Soluble urokinase receptor and acute kidney injury","volume":"382","author":"Hayek","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"2025122309411098000_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.26444\/aaem\/167464","article-title":"A comprehensive review and meta-analysis of suPAR as a predictor of acute kidney injury","volume":"30","author":"Jankowski","year":"2023","journal-title":"Ann Agric Environ Med"},{"issue":"1","key":"2025122309411098000_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10157-022-02300-2","article-title":"Predictive value of suPAR in AKI: a systematic review and meta-analysis","volume":"27","author":"Huang","year":"2023","journal-title":"Clin Exp Nephrol"},{"issue":"17","key":"2025122309411098000_bib15","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1200\/JCO.20.00619","article-title":"Acute GVHD diagnosis and adjudication in a Multicenter trial: a report from the BMT CTN 1202 biorepository study","volume":"39","author":"Reshef","year":"2021","journal-title":"J Clin Oncol"},{"key":"2025122309411098000_bib16","unstructured":"Wisconsin Diagnostic Laboratories\n          . Serum Creatinine. Accessed 10 March 2025. https:\/\/www.testmenu.com\/wisconsindiagnostic\/Tests\/895915."},{"issue":"1","key":"2025122309411098000_bib17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc11454","article-title":"Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1)","volume":"17","author":"Kellum","year":"2013","journal-title":"Crit Care"},{"key":"2025122309411098000_bib18","doi-asserted-by":"crossref","first-page":"779881","DOI":"10.3389\/fimmu.2021.779881","article-title":"Recent advances of acute kidney injury in hematopoietic cell transplantation","volume":"12","author":"Miyata","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"2025122309411098000_bib19","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1681\/ASN.2011090907","article-title":"Biomarkers predict progression of acute kidney injury after cardiac surgery","volume":"23","author":"Koyner","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2025122309411098000_bib20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/10408363.2021.1879000","article-title":"Current concepts and advances in biomarkers of acute kidney injury","volume":"58","author":"Wen","year":"2021","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"10","key":"2025122309411098000_bib21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41581-019-0184-x","article-title":"Molecular nephrology: types of acute tubular injury","volume":"15","author":"Desanti De Oliveira","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"2025122309411098000_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cca.2022.08.029","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) in kidney injury - a systematic review","volume":"536","author":"Marakala","year":"2022","journal-title":"Clin Chim Acta"},{"issue":"pt 3","key":"2025122309411098000_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/0004563214521795","article-title":"Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status","volume":"51","author":"Haase-Fielitz","year":"2014","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"2025122309411098000_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.5812\/numonthly.5002","article-title":"Comparison of serum and urine neutrophil gelatinase-associated lipocalin (NGAL) with serum creatinine in prediction of kidney suitability for transplantation","volume":"5","author":"Mahdavi-Mazdeh","year":"2013","journal-title":"Nephrourol Mon"},{"issue":"6","key":"2025122309411098000_bib25","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3109\/0886022X.2015.1040699","article-title":"Urine neutrophil gelatinase associated lipocalin as an early marker of acute kidney injury in hematopoietic stem cell transplantation patients","volume":"37","author":"Taghizadeh-Ghehi","year":"2015","journal-title":"Ren Fail"},{"issue":"1","key":"2025122309411098000_bib26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.6002\/ect.2016.0161","article-title":"Early diagnostic markers for detection of acute kidney injury in allogeneic hematopoietic stem cell transplant recipients","volume":"18","author":"Deger","year":"2020","journal-title":"Exp Clin Transplant"},{"issue":"11","key":"2025122309411098000_bib27","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1681\/ASN.2020060829","article-title":"Soluble urokinase receptor (SuPAR) in COVID-19-related AKI","volume":"31","author":"Azam","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"2025122309411098000_bib28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/ph14090843","article-title":"Utility of suPAR and NGAL for AKI risk stratification and early optimization of renal risk medications among older patients in the emergency department","volume":"14","author":"Walls","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"2025122309411098000_bib29","doi-asserted-by":"crossref","first-page":"780641","DOI":"10.3389\/fimmu.2021.780641","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of systemic chronic inflammation","volume":"12","author":"Rasmussen","year":"2021","journal-title":"Front Immunol"},{"issue":"7","key":"2025122309411098000_bib30","doi-asserted-by":"crossref","first-page":"e165740","DOI":"10.1172\/jci.insight.165740","article-title":"suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injury","volume":"8","author":"Nusshag","year":"2023","journal-title":"JCI Insight"},{"key":"2025122309411098000_bib31","doi-asserted-by":"crossref","first-page":"10071","DOI":"10.3389\/ti.2021.10071","article-title":"Soluble urokinase receptor and mortality in kidney transplant recipients","volume":"35","author":"Morath","year":"2021","journal-title":"Transpl Int"},{"issue":"5","key":"2025122309411098000_bib32","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ekir.2018.05.004","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) and all-cause and cardiovascular mortality in diverse hemodialysis patients","volume":"3","author":"Torino","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"12","key":"2025122309411098000_bib33","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/j.bbmt.2020.08.029","article-title":"A new standard in graft-versus-host disease prophylaxis? An introduction to Blood and Marrow Transplant Clinical Trials Network 1703","volume":"26","author":"DeFilipp","year":"2020","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/24\/6394\/2474744\/blooda_adv-2025-016655-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/24\/6394\/2474744\/blooda_adv-2025-016655-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T14:41:23Z","timestamp":1766500883000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/24\/6394\/547435\/Soluble-urokinase-plasminogen-activator-receptor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":33,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2025,12,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016655","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12,23]]},"published":{"date-parts":[[2025,12,11]]}}}